Characterization of discriminant human brain antigenic targets in neuropsychiatric systemic lupus erythematosus using an immunoproteomic approach
- 28 September 2007
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 56 (10) , 3420-3432
Abstract
Objective: To characterize discriminant human brain antigenic targets in patients with neuropsychiatric systemic lupus erythematosus (NPSLE), using a standardized immunoproteomic approach.Methods: Self‐IgG reactivity against normal and injured human brain tissues was studied by Western blotting of sera from 169 subjects, 16 patients with NPSLE, 12 patients with SLE without neuropsychiatric manifestations (non‐NPSLE), 32 patients with Sjögren's syndrome with or without central nervous involvement, 82 patients with multiple sclerosis, and 27 healthy subjects. A proteomic approach was then applied to characterize discriminant antigens identified after comparisons of all patterns.Results: The serum self‐IgG reactivity patterns against human brain tissue differed significantly between patients with NPSLE and the control groups. Four normal brain antigenic bands were specifically or preferentially recognized by sera from NPSLE patients (p240, p90, p77, and p24). Protein band p240 was characterized as microtubule‐associated protein 2B (MAP‐2B), p77 as Hsp70–71, and p24 as triosephosphate isomerase. Protein band p90 was not characterized. In contrast, 1 other protein band (p56, characterized as septin 7) was never recognized by sera from NPSLE patients but was recognized by a majority of sera from non‐NPSLE patients.Conclusion: Our findings show that the immunoproteomic approach is a reliable method for assessing serum self‐IgG reactivities against human brain tissue in NPSLE. Our characterization of some of the identified discriminant antigens, such as MAP‐2B, triosephosphate isomerase, and septin 7, suggests that the stability of neuronal microtubules might be involved in the pathophysiology of NPSLE.Keywords
This publication has 51 references indexed in Scilit:
- Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: An international inception cohort studyArthritis & Rheumatism, 2007
- Human lupus autoantibodies against NMDA receptors mediate cognitive impairmentProceedings of the National Academy of Sciences, 2006
- Raised monocyte chemotactic protein-1 (MCP-1)/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupusAnnals of the Rheumatic Diseases, 2006
- Neuroprotective effects of HSP70 overexpression after cerebral ischaemia—An MRI studyExperimental Neurology, 2005
- Elevated levels of soluble fractalkine in active systemic lupus erythematosus: Potential involvement in neuropsychiatric manifestationsArthritis & Rheumatism, 2005
- Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus GroupAnnals of the Rheumatic Diseases, 2002
- Identification of antibodies to heat shock proteins 90 kDa and 70 kDa in patients with schizophreniaSchizophrenia Research, 2001
- Autoantibodies: Terms and conceptsClinical Immunology and Immunopathology, 1988
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970